A Randomized, Open-Label, Controlled, Multi-Center Trial to Evaluate the Contraceptive Efficacy, Cycle Control, Safety and Acceptability of NuvaRing (SCH 900702) in Chinese Women.
Phase of Trial: Phase III
Latest Information Update: 05 Jul 2017
At a glance
- Drugs Ethinylestradiol/etonogestrel (Primary) ; Drospirenone/ethinylestradiol
- Indications Pregnancy
- Focus Therapeutic Use
- Sponsors Merck & Co
- 01 Sep 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 14 May 2013 Planned end date changed from 1 Aug 2013 to 1 Sep 2013 as reported by ClinicalTrials.gov.
- 18 Jul 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.